-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Smith & Nephew (LON:SN) Stock Rating Reaffirmed by Royal Bank of Canada
Smith & Nephew (LON:SN) Stock Rating Reaffirmed by Royal Bank of Canada
Royal Bank of Canada reaffirmed their sector perform rating on shares of Smith & Nephew (LON:SN – Get Rating) in a research note published on Tuesday morning, MarketBeat reports. Royal Bank of Canada currently has a GBX 1,500 ($18.12) target price on the stock.
SN has been the subject of a number of other research reports. Credit Suisse Group reduced their target price on shares of Smith & Nephew from GBX 1,540 ($18.61) to GBX 1,400 ($16.92) and set an outperform rating for the company in a research report on Thursday, August 4th. Barclays lowered their target price on shares of Smith & Nephew from GBX 1,630 ($19.70) to GBX 1,550 ($18.73) and set an overweight rating on the stock in a report on Thursday, August 4th. Berenberg Bank cut their price target on Smith & Nephew from GBX 1,800 ($21.75) to GBX 1,400 ($16.92) and set a buy rating for the company in a research note on Thursday, September 8th. Finally, JPMorgan Chase & Co. dropped their price objective on Smith & Nephew from GBX 1,442 ($17.42) to GBX 1,243 ($15.02) and set a neutral rating for the company in a report on Thursday, August 4th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Smith & Nephew currently has an average rating of Moderate Buy and an average target price of GBX 1,418.60 ($17.14).
Get Smith & Nephew alerts:Smith & Nephew Stock Performance
LON:SN opened at GBX 1,060 ($12.81) on Tuesday. The stock has a 50 day simple moving average of GBX 1,085.96 and a 200 day simple moving average of GBX 1,183.27. The stock has a market cap of £9.23 billion and a P/E ratio of 2,216.67. Smith & Nephew has a 1-year low of GBX 994.80 ($12.02) and a 1-year high of GBX 1,379.60 ($16.67). The company has a current ratio of 1.78, a quick ratio of 0.84 and a debt-to-equity ratio of 53.62.
Smith & Nephew Cuts Dividend
The firm also recently declared a dividend, which will be paid on Wednesday, October 26th. Stockholders of record on Thursday, September 29th will be issued a dividend of $0.14 per share. The ex-dividend date of this dividend is Thursday, September 29th. This represents a dividend yield of 0.99%. Smith & Nephew's dividend payout ratio (DPR) is currently 6,250.00%.Insider Activity at Smith & Nephew
In related news, insider Erik Engstrom purchased 332 shares of Smith & Nephew stock in a transaction dated Tuesday, August 23rd. The shares were bought at an average cost of GBX 1,010 ($12.20) per share, for a total transaction of £3,353.20 ($4,051.72).
About Smith & Nephew
(Get Rating)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.
See Also
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It's a Down Week
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.
Royal Bank of Canada reaffirmed their sector perform rating on shares of Smith & Nephew (LON:SN – Get Rating) in a research note published on Tuesday morning, MarketBeat reports. Royal Bank of Canada currently has a GBX 1,500 ($18.12) target price on the stock.
据MarketBeat报道,加拿大皇家银行在周二上午发布的一份研究报告中重申了他们对Smith&Nephew(伦敦股票代码:SN-GET)股票的行业表现评级。加拿大皇家银行目前对该股的目标价为1,500英镑(合18.12美元)。
SN has been the subject of a number of other research reports. Credit Suisse Group reduced their target price on shares of Smith & Nephew from GBX 1,540 ($18.61) to GBX 1,400 ($16.92) and set an outperform rating for the company in a research report on Thursday, August 4th. Barclays lowered their target price on shares of Smith & Nephew from GBX 1,630 ($19.70) to GBX 1,550 ($18.73) and set an overweight rating on the stock in a report on Thursday, August 4th. Berenberg Bank cut their price target on Smith & Nephew from GBX 1,800 ($21.75) to GBX 1,400 ($16.92) and set a buy rating for the company in a research note on Thursday, September 8th. Finally, JPMorgan Chase & Co. dropped their price objective on Smith & Nephew from GBX 1,442 ($17.42) to GBX 1,243 ($15.02) and set a neutral rating for the company in a report on Thursday, August 4th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Smith & Nephew currently has an average rating of Moderate Buy and an average target price of GBX 1,418.60 ($17.14).
SN已经成为许多其他研究报告的主题。瑞士信贷集团将Smith&Nephew的股票目标价从1,540英镑(18.61美元)下调至1,400英镑(16.92美元),并在8月4日星期四的一份研究报告中为该公司设定了表现优于大盘的评级。巴克莱将Smith&Nephew股票的目标价从1,630英镑(19.70美元)下调至1,550英镑(18.73美元),并在8月4日周四的一份报告中设定了该股的增持评级。贝伦伯格银行将Smith&Nephew的目标价从1,800英镑(21.75美元)下调至1,400英镑(16.92美元),并在9月8日周四的一份研究报告中为该公司设定了买入评级。最后,摩根大通在8月4日周四的一份报告中将Smith&Nephew的目标价从1,442英镑(合17.42美元)下调至1,243英镑(合15.02美元),并将该公司的评级定为中性。三位投资分析师对该股的评级为持有,三位分析师对该股的评级为买入。根据MarketBeat的数据,Smith&Nephew目前的平均评级为中等买入,平均目标价为1,418.60英镑(合17.14美元)。
Smith & Nephew Stock Performance
Smith&Nephew股票表现
LON:SN opened at GBX 1,060 ($12.81) on Tuesday. The stock has a 50 day simple moving average of GBX 1,085.96 and a 200 day simple moving average of GBX 1,183.27. The stock has a market cap of £9.23 billion and a P/E ratio of 2,216.67. Smith & Nephew has a 1-year low of GBX 994.80 ($12.02) and a 1-year high of GBX 1,379.60 ($16.67). The company has a current ratio of 1.78, a quick ratio of 0.84 and a debt-to-equity ratio of 53.62.
Lon:SN周二开盘报1,060英镑(合12.81美元)。该股的50日简单移动均线为1,085.96英镑,200天简单移动均线为1,183.27英镑。该股市值为92.3亿GB,市盈率为2216.67倍。Smith&Nephew的一年低点为994.80英镑,一年高位为1,379.60英镑。该公司的流动比率为1.78,速动比率为0.84,债务权益比率为53.62。
Smith & Nephew Cuts Dividend
Smith&Nephew削减股息
Insider Activity at Smith & Nephew
Smith&Nephew的内幕活动
In related news, insider Erik Engstrom purchased 332 shares of Smith & Nephew stock in a transaction dated Tuesday, August 23rd. The shares were bought at an average cost of GBX 1,010 ($12.20) per share, for a total transaction of £3,353.20 ($4,051.72).
在相关新闻中,内部人士埃里克·恩斯特罗姆在一笔日期为8月23日(星期二)的交易中购买了332股Smith&Nephew股票。这些股票的平均价格为每股1,010英镑(12.20美元),总交易额为3,353.20英镑(4,051.72美元)。
About Smith & Nephew
关于Smith&Nephew
(Get Rating)
(获取评级)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.
Smith&Nephew plc及其子公司在全球范围内开发、制造、营销和销售医疗器械。该公司提供用于膝关节置换手术的膝关节植入物产品;用于重建髋关节的髋关节植入物;以及包括用于稳定严重骨折和畸形矫正程序的内部和外部设备的创伤和肢体产品。
See Also
另请参阅
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It's a Down Week
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
- 有什么办法可以治愈Teladoc股票的问题吗?
- 没有人告诉这三只股票这是下跌的一周
- 为什么医疗产品制造商Repligen可能成为潜在收购对象
- 在10%的水平上,Arbor Realty Trust的股息值得吗?
- 投资者应关注RF Industries
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.
接受Smith和Nephew Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Smith&Nephew和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧